Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The scoop: Marathon’s R&D program for Duchenne MD drug likely came in at a bargain basement price
The scoop: Marathon’s R&D program for Duchenne MD drug likely came in at a bargain basement price
The scoop: Marathon’s R&D program for Duchenne MD drug likely came in at a bargain basement price
Submitted by
admin
on February 13, 2017 - 10:00am
Source:
Endpoints
News Tags:
Marathon Pharma
R&D
Duchenne Muscular Dystrophy
Emflaza
Headline:
The scoop: Marathon’s R&D program for Duchenne MD drug likely came in at a bargain basement price
Do Not Allow Advertisers to Use My Personal information
